Clinical Trials Logo

Clinical Trial Summary

This A Three-Part Drug-Drug Interaction Study To Evaluate Effects of Casopitant On Dolasetron, Granisetron or Rosiglitazone When Co-Administered in Healthy Adults


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Nausea and Vomiting, Chemotherapy-Induced
  • Vomiting

NCT number NCT00511823
Study type Interventional
Source GlaxoSmithKline
Contact
Status Completed
Phase Phase 1
Start date July 23, 2007
Completion date September 21, 2007

See also
  Status Clinical Trial Phase
Completed NCT00404378 - Study Of Healthy Subjects To Assess The Effect Of Ketoconazole And The Way The Body Will React To Casopitant [GW679769] Phase 1
Completed NCT00431236 - A Study of the Drug Casopitant for the Prevention of Nausea Caused By Cisplatin-Based Highly Emetogenic Chemotherapy Phase 3
Completed NCT00405080 - A Study in Healthy Subjects to Assess How Dosing of Rifampin Affects What the Body Does to a Dose of GW679769 (Casopitant). Phase 1
Completed NCT00404274 - A Study Testing the Effect and Safety of Casopitant (GW679769) While Taking Warfarin in Healthy Human Volunteers Phase 1
Completed NCT00440128 - The Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In Subjects With Cancer Phase 1
Completed NCT00601172 - A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting. Phase 3
Completed NCT00366834 - Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting Phase 3
Completed NCT00437229 - A Study to Assess the Safety & Interaction Between GW679769, Dexamethasone, & Ondansetron When Taken by Healthy Adults Phase 1
Completed NCT00104403 - Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy Phase 2
Completed NCT01449188 - To Investigate the Effect of Intravenous Ondansetron on Cardiac Conduction as Compared to Placebo and Moxifloxacin in Healthy Adult Subjects Phase 1
Terminated NCT00334646 - Cyclophosphamide Drug Interaction Study In Cancer Patients Phase 1
Completed NCT00460707 - A Study to Assess the Safety and Interaction Between Casopitant and Ketoconazole When Taken By Healthy Adults Phase 1